Roland Preece

909 total citations · 1 hit paper
12 papers, 500 citations indexed

About

Roland Preece is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Roland Preece has authored 12 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Roland Preece's work include CAR-T cell therapy research (11 papers), CRISPR and Genetic Engineering (9 papers) and Virus-based gene therapy research (5 papers). Roland Preece is often cited by papers focused on CAR-T cell therapy research (11 papers), CRISPR and Genetic Engineering (9 papers) and Virus-based gene therapy research (5 papers). Roland Preece collaborates with scholars based in United Kingdom, India and Singapore. Roland Preece's co-authors include Christos Georgiadis, Waseem Qasim, Annie Etuk, Jane Rasaiyaah, Soragia Athina Gkazi, Ulrike Mock, Jin‐Soo Kim, Daesik Kim, David O’Connor and Kimberly Gilmour and has published in prestigious journals such as New England Journal of Medicine, Blood and Molecular Therapy.

In The Last Decade

Roland Preece

10 papers receiving 483 citations

Hit Papers

Base-Edited CAR7 T Cells for Relapsed T-Cell Acute Lympho... 2023 2026 2024 2025 2023 50 100 150

Peers

Roland Preece
Annie Etuk United Kingdom
Diane Le Clerre Netherlands
Laëtitia Lemaire United Kingdom
Jessica Perazzelli United States
Pierrick Potrel United Kingdom
Dana Stenger Germany
Leila Mekkaoui United Kingdom
Annie Etuk United Kingdom
Roland Preece
Citations per year, relative to Roland Preece Roland Preece (= 1×) peers Annie Etuk

Countries citing papers authored by Roland Preece

Since Specialization
Citations

This map shows the geographic impact of Roland Preece's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roland Preece with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roland Preece more than expected).

Fields of papers citing papers by Roland Preece

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roland Preece. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roland Preece. The network helps show where Roland Preece may publish in the future.

Co-authorship network of co-authors of Roland Preece

This figure shows the co-authorship network connecting the top 25 collaborators of Roland Preece. A scholar is included among the top collaborators of Roland Preece based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roland Preece. Roland Preece is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Chiesa, Robert, Christos Georgiadis, Hani Rashed, et al.. (2025). Universal Base-Edited CAR7 T Cells for T-Cell Acute Lymphoblastic Leukemia. New England Journal of Medicine. 394(2). 152–165.
2.
Georgiadis, Christos, Roland Preece, & Waseem Qasim. (2025). Clinical development of allogeneic chimeric antigen receptor αβ-T cells. Molecular Therapy. 33(6). 2426–2440. 3 indexed citations
3.
Georgiadis, Christos, Arnold Kloos, Amit D. Joshi, et al.. (2025). Base edited “universal” donor CAR T-cell strategies for acute myeloid leukaemia. Leukemia. 39(12). 2978–2987.
4.
Georgiadis, Christos, Lauren Nickolay, Farhatullah Syed, et al.. (2024). Umbilical cord blood T cells can be isolated and enriched by CD62L selection for use in 'off the shelf' chimeric antigen receptor T-cell therapies to widen transplant options. Haematologica. 109(12). 3941–3951. 2 indexed citations
5.
Chiesa, Robert, Christos Georgiadis, Farhatullah Syed, et al.. (2023). Base-Edited CAR7 T Cells for Relapsed T-Cell Acute Lymphoblastic Leukemia. New England Journal of Medicine. 389(10). 899–910. 174 indexed citations breakdown →
6.
Georgiadis, Christos, Jane Rasaiyaah, Soragia Athina Gkazi, et al.. (2021). Base-edited CAR T cells for combinational therapy against T cell malignancies. Leukemia. 35(12). 3466–3481. 89 indexed citations
7.
Preece, Roland, Andrea Pavesi, Soragia Athina Gkazi, et al.. (2020). CRISPR-Mediated Base Conversion Allows Discriminatory Depletion of Endogenous T Cell Receptors for Enhanced Synthetic Immunity. Molecular Therapy — Methods & Clinical Development. 19. 149–161. 20 indexed citations
8.
Preece, Roland, et al.. (2020). ‘Mini’ U6 Pol III promoter exhibits nucleosome redundancy and supports multiplexed coupling of CRISPR/Cas9 effects. Gene Therapy. 27(9). 451–458. 9 indexed citations
9.
Preece, Roland & Christos Georgiadis. (2019). Emerging CRISPR/Cas9 applications for T-cell gene editing. Emerging Topics in Life Sciences. 3(3). 261–275. 2 indexed citations
10.
Georgiadis, Christos, Jane Rasaiyaah, Soragia Athina Gkazi, et al.. (2019). Universal' Fratricide-Resistant CAR T Cells Against T Cell Leukemia Generated By Coupled & Uncoupled Deamination Mediated Base Editing. Blood. 134(Supplement_1). 3219–3219. 3 indexed citations
11.
Rasaiyaah, Jane, Christos Georgiadis, Roland Preece, Ulrike Mock, & Waseem Qasim. (2018). TCRαβ/CD3 disruption enables CD3-specific antileukemic T cell immunotherapy. JCI Insight. 3(13). 79 indexed citations
12.
Georgiadis, Christos, Roland Preece, Lauren Nickolay, et al.. (2018). Long Terminal Repeat CRISPR-CAR-Coupled “Universal” T Cells Mediate Potent Anti-leukemic Effects. Molecular Therapy. 26(5). 1215–1227. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026